Samsung Bioepis
Samsung Bioepis is a South Korea-based biopharmaceutical firm specializing in biosimilar medicines, formed as a joint venture combining Samsung Biologics' manufacturing scale with biologics development expertise. Beyond its own pipeline, it co-invests in biotech and gene-therapy startups through the jointly established Samsung Life Science Fund.
Incheon · 1+ investments · 1 portfolio companies
- Headquarters
- Incheon
- Founded
- 2012
- Portfolio Company
- 1
- Total Investment
- 1
- Last Investment
- May 2024
- Geographic Focus
- United States
Indexed holds 1 portfolio company and 1 funding round for this investor. The full record is or through the API.
Investment Thesis
Samsung Bioepis is a Venture Capital firm based in Incheon. It has made 1 investment, including Latus Bio. Focus areas include Biotech and Digital Health.
Portfolio1
Co-investors4
Sign up to view co-investors
4 co-investors across 4 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×4 · 4 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/samsung-bioepis"><img src="https://indexed.vc/api/badge/investor/samsung-bioepis" alt="Samsung Bioepis on Indexed.vc" width="260" height="76" /></a>